Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513162-22-000008
Filing Date
2022-01-12
Accepted
2022-01-12 16:13:30
Documents
47
Period of Report
2021-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bmra-20211130.htm   iXBRL 10-Q 1122018
2 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 8217
3 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 8972
4 EXHIBIT 32.1 exhibit32_1.htm EX-32.1 4323
5 EXHIBIT 32.2 exhibit32_2.htm EX-32.2 4406
  Complete submission text file 0001513162-22-000008.txt   4632827

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmra-20211130.xsd EX-101.SCH 29966
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmra-20211130_cal.xml EX-101.CAL 32363
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmra-20211130_def.xml EX-101.DEF 186094
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bmra-20211130_lab.xml EX-101.LAB 305706
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmra-20211130_pre.xml EX-101.PRE 193141
41 EXTRACTED XBRL INSTANCE DOCUMENT bmra-20211130_htm.xml XML 682762
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9496452111
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 001-37863 | Film No.: 22526724
SIC: 2835 In Vitro & In Vivo Diagnostic Substances